Thursday, December 14, 2017 5:46:34 PM
The success of the recent tests along with growing interest both domestically and abroad demonstrate that this technology is desirable and might just be successful in spite of any perceived failings of management.
They have weathered the storm of the Obama years, and no doubt if needed, CCTI can tread water for many years to come. However, the future is looking bright, and for those with enough patience, there just might be a pot of golden coal at the end of the rainbow.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM